Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.119 - kallikrein 13

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma of Lung
Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation.
Breast Neoplasms
Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity.
Carcinogenesis
Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay.
Carcinoma
Correction to: Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer.
Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas.
Carcinoma, Non-Small-Cell Lung
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.
Carcinoma, Ovarian Epithelial
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
Colonic Neoplasms
Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay.
Diabetic Cardiomyopathies
Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.
Dry Eye Syndromes
Autoantibodies Contribute to the Immunopathogenesis of Experimental Dry Eye Disease.
Esophageal Squamous Cell Carcinoma
Correction to: Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Hyperglycemia
Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.
Hypertension
Kallikrein-like prorenin-converting enzymes in inbred hypertensive mice.
Renin activity and angiotensin I concentration in genetically selective inbred line of hypertensive mice.
Infections
Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1.
Lung Neoplasms
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.
Mouth Neoplasms
Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer.
Neoplasm Metastasis
Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer.
Neoplasms
Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation.
Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Human kallikrein 13 expression in salivary gland tumors.
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
Ovarian Neoplasms
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Squamous Cell Carcinoma of Head and Neck
Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer.
Stomach Neoplasms
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.